| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.0045 | 1 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |